Study title: A double-blind randomized, placebo-controlled study of the protective efficacy of SmithKline Beecham Biologicals' inactivated hepatitis A vaccine in healthy children.
| Type of medicine: Non-centrally authorised vaccines | |||||
| Therapeutic area: Virus Diseases | |||||
| Brands: Please see report, Please see report, Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: Inactivated hepatitis A virus | |||||
| ATC code: | |||||
| Document link: | |||||
| Document date: 2011-09-23 | |||||
| Study number: 208109/100 Annex Report 2 | |||||
| EudraCT number: | |||||
| Scope of study: CLINICAL | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | - | - | |